Denali Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Denali Advisors's PFE Position: Q3 2025 in Review
Denali Advisors sold out of Pfizer (PFE) in Q3 2025, closing a stake of 31,700 shares — an estimated $768K sold.
Denali Advisors first reported a position in PFE in Q4 2019 and held it in 13 quarters. The position peaked at $8.28M in Q4 2019. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Denali Advisors reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Denali Advisors sold 31,700 Pfizer shares in Q3 2025, an estimated $768K.
- Denali Advisors first reported a position in Pfizer in Q4 2019 and held it in 13 quarters.
- Denali Advisors's Pfizer position peaked at $8.28M in Q4 2019.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Denali Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.